Aislaitner G - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

The metabolism of alicyclic amines to reactive iminium ion intermediates.

Gorrod JW, Aislaitner G. Gorrod JW, et al. Among authors: aislaitner g. Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):209-17. doi: 10.1007/BF03188923. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867663 Review.

Metabolism of (-)-(S)-nicotine in the isolated perfused rabbit lung.

Aislaitner G, Bello A, Tan SC, Hutt AJ, Marriott C, Gorrod JW. Aislaitner G, et al. Eur J Drug Metab Pharmacokinet. 1997 Oct-Dec;22(4):395-402. doi: 10.1007/BF03190976. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9512940

Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole.

Silva MT, Rose S, Hindmarsh JG, Aislaitner G, Gorrod JW, Moore PK, Jenner P, Marsden CD. Silva MT, et al. Among authors: aislaitner g. Br J Pharmacol. 1995 Jan;114(2):257-8. doi: 10.1111/j.1476-5381.1995.tb13219.x. Br J Pharmacol. 1995. PMID: 7533610 Free PMC article.

European Union pharmacovigilance capabilities: potential for the new legislation.

Borg JJ, Tanti A, Kouvelas D, Lungu C, Pirozynski M, Serracino-Inglott A, Aislaitner G. Borg JJ, et al. Among authors: aislaitner g. Ther Adv Drug Saf. 2015 Aug;6(4):120-40. doi: 10.1177/2042098615591802. Ther Adv Drug Saf. 2015. PMID: 26301067 Free PMC article. Review.

Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective.

Borg JJ, Tomasi P, Pani L, Aislaitner G, Pirozynski M, Leufkens H, Melchiorri D. Borg JJ, et al. Among authors: aislaitner g. Sci Pharm. 2014 May 22;82(4):847-56. doi: 10.3797/scipharm.1312-10. Print 2014 Oct-Dec. Sci Pharm. 2014. PMID: 26171329 Free PMC article.

Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.

Borg JJ, Aislaitner G, Pirozynski M, Mifsud S. Borg JJ, et al. Among authors: aislaitner g. Drug Saf. 2011 Mar 1;34(3):187-97. doi: 10.2165/11586620-000000000-00000. Drug Saf. 2011. PMID: 21332243 Review.

Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal Products.

Borg JJ, Robert JL, Wade G, Aislaitner G, Pirozynski M, Abadie E, Salmonson T, Vella Bonanno P. Borg JJ, et al. Among authors: aislaitner g. J Pharm Pharm Sci. 2009;12(2):181-98. doi: 10.18433/j3fw2q. J Pharm Pharm Sci. 2009. PMID: 19732496 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results